Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 2
2018 pubmed 12 citations

The host defense peptide LL-37 triggers release of nucleic acids from human mast cells.

Dahl. Sara S; Anders. Emma E; Gidlöf. Olof O; Svensson. Daniel D; Nilsson. Bengt-Olof BO

Key Findings

  • LL-37 is taken up by mast cells and localizes to both cytoplasm and nucleus
  • High concentrations (4‑10 µM) reduce mast cell viability and cause release of nucleic acids, total protein, and LDH
  • LL-37 triggers nucleic acid release without forming extracellular trap‑like structures, unlike PMA

Practical Outcomes

  • For DIY health enthusiasts, the data suggest that using LL-37 at high concentrations could damage mast cells and provoke unwanted inflammation, so staying at low micromolar levels (around 1 µM) appears safer in vitro. However, human effects are unknown, so caution and further research are needed before any self‑administration.

Summary

The study shows that the antimicrobial peptide LL-37 can get inside human mast cells and, at relatively high levels (4‑10 µM), it hurts the cells and makes them spill their DNA, proteins and enzymes, but it doesn’t cause the cells to form the usual “net‑like” traps seen with other stimulants. Lower doses (1 µM) didn’t harm the cells in the lab test.

Abstract

The human host defense peptide LL-37 possesses antimicrobial activity but also affects host cell function and viability. Mast cells are involved in innate immunity but no data have been presented on effects of LL-37 on human mast cell viability and export of nucleic acids. Here, we demonstrated by immunofluorescence microscopy that synthesized LL-37 was internalized by human LAD2 mast cells and detected both in cytoplasm and nucleus. Treatment with high (4 and 10 μM) but not low (1 μM) concentrations of LL-37 for 4 h reduced cell viability assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Stimulation with 10 μM LL-37 for 4 h enhanced export of nucleic acids, total protein and lactate dehydrogenase (LDH), suggesting that both nuclear and plasma membranes are permeabilized by LL-37. Although LL-37 triggered release of nucleic acids, no extracellular trap-like structures were observed by laser scanning confocal microscopy of cells incubated with the plasma membrane impermeable nucleic acid fluorophore SYTOX-Green, indicating that LL-37 promotes export of nucleic acids but not formation of extracellular traps. On the other hand, phorbol-12-myristate-13-acetate (PMA), which is a well-known inducer of extracellular traps, stimulated export of nucleic acids and also formation of extracellular trap-like structures. However, PMA had no effect on export of either total protein or LDH. Hence, LL-37 and PMA seem to stimulate export of nucleic acids from LAD2 mast cells through different pathways. In conclusion, we demonstrate that LL-37 triggers release of nucleic acids from human mast cells but not the formation of extracellular trap-like structures.

Study Information

Provider

pubmed

Year

2018

Date

2018-10-09T00:00:00.000Z

DOI

10.1016/j.peptides.2018.10.001

Citations

12

References

30